Respiratory syncytial virus genotypes, host immune profles, and disease severity in young children hospitalized with bronchioliThis

Journal of Infectious Diseases

Volumn 217, Issue 1, 2018, Pages 24-34

  Rodriguez Fernandez, Rosa ^a,f   Tapia, Lorena I ^b,g   Yang, Chin Fen ^c,h   Torres, Juan Pablo ^d,g   Chavez Bueno, Susana ^d,i   Garcia, Carla ^d,j   Jaramillo, Lisa M ^a   Moore Clingenpeel, Melissa ^e   Jafri, Hasan S ^d,k   Peeples, Mark E ^a   Piedra, Pedro A ^b   Ramilo, Octavio ^a   Mejias, Asuncion ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MEDIMMUNE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Center for BiostaThistics   (United States)

^f HOSPITAL MATERNO INFANTIL GREGORIO MARAÑÓN   (Spain)

^g UNIVERSITY OF CHILE   (Chile)

^h Enimmune Corporation   (Taiwan)

ⁱ CHILDREN S MERCY HOSPITAL   (United States)

^j PID Associ   (United States)

^k Medimmune AztraZeneca   (United States)

more..

Author keywords

BronchioliThis; Genomic loads; Host responses; RSV

Indexed keywords

INTERFERON;

AGE; ARTICLE; BRONCHIOLITIS; CHILD; CLINICAL DISEASE SEVERITY SCORE; CLINICAL OUTCOME; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; ETHNIC DIFFERENCE; FEMALE; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENOTYPE; HOSPITALIZATION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS A; HUMAN RESPIRATORY SYNCYTIAL VIRUS B; IMMUNE RESPONSE; IMMUNITY; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PEDIATRIC INTENSIVE CARE UNIT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS LOAD; CLASSIFICATION; GENE EXPRESSION PROFILING; GENETIC VARIATION; GENETICS; GENOTYPING TECHNIQUE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; NASOPHARYNX; NEUTROPHIL; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VIRAL BRONCHIOLITIS; VIROLOGY;

BRONCHIOLITIS, VIRAL; FEMALE; GENE EXPRESSION PROFILING; GENETIC VARIATION; GENOTYPE; GENOTYPING TECHNIQUES; HOSPITALIZATION; HUMANS; INFANT; INTERFERONS; LENGTH OF STAY; MALE; NASOPHARYNX; NEUTROPHILS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 85044064807     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix543     Document Type: Article

References (50)

1. Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002; 21:629-32.
2. McConnochie KM, Hall CB, Walsh EE, Roghmann KJ. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr 1990; 117:52-62.
3. Imaz MS, Sequeira MD, Videla C, et al. Clinical and epide-miologic characteristics of respiratory syncytial virus subgroups A and B infections in Santa Fe, Argentina. J Med Virol 2000; 61:76-80.
4. Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis 1997; 175:814-20.
5. Jafri HS, Wu X, Makari D, Henrickson KJ. Distribution of respiratory syncytial virus subtypes A and B among infants presenting to the emergency department with lower respiratory tract infection or apnea. Pediatr Infect Dis J 2013; 32:335-40.
6. Brouard J, Freymuth F, Constantini S, Petitjean J, de Schrevel G, Duhamel JF. Prevalence and clinical aspects of A and B subgroups of respiratory syncytial virus infection. Observation of 8 consecutive epidemics between 1982 and 1990. Arch Fr Pediatr 1993; 50:639-43.
7. McIntosh ED, De Silva LM, Oates RK. Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia. Pediatr Infect Dis J 1993; 12:815-9.
8. Kneyber MC, Brandenburg AH, Rothbarth PH, de Groot R, Ott A, van Steensel-Moll HA. Relationship between clinical severity of respiratory syncytial virus infection and subtype. Arch Dis Child 1996; 75:137-40.
9. Esposito S, Piralla A, Zampiero A, et al. Characteristics and their clinical relevance of respiratory syncytial virus types and genotypes circulating in Northern Italy in fve consecutive winter seasons. PLoS One 2015; 10:e0129369.
10. Fodha I, Vabret A, Ghedira L, et al. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol 2007; 79:1951-8.
11. Gilca R, De Serres G, Tremblay M, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis 2006; 193:54-8.
12. Martinello RA, Chen MD, Weibel C, Kahn JS. Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis 2002; 186:839-42.
13. Papadopoulos NG, Gourgiotis D, Javadyan A, et al. Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants? Respir Med 2004; 98:879-82.
14. Smyth RL, Mobbs KJ, O'Hea U, Ashby D, Hart CA. Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype. Pediatr Pulmonol 2002; 33:339-46.
15. Otieno JR, Kamau EM, Agoti CN, et al. Spread and evolution of respiratory syncytial virus A genotype ON1, Coastal Kenya, 2010-2015. Emerg Infect Dis 2017; 23:264-71.
16. Espinosa Y, San Martin C, Torres AA, et al. Genomic loads and genotypes of respiratory syncytial virus: viral factors during lower respiratory tract infection in Chilean hospitalized infants. Int J Mol Sci 2017; 18:E654.
17. Levitz R, Wattier R, Phillips P, et al. Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specifc. Virol J 2012; 9:190.
18. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118:1774-93.
19. Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999; 18:115-22.
20. Gill MA, Long K, Kwon T, et al. Diferential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with infuenza virus or respiratory syncytial virus infection. J Infect Dis 2008; 198:1667-76.
21. Mella C, Suarez-Arrabal MC, Lopez S, et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2013; 207:564-73.
22. García C, Soriano-Fallas A, Lozano J, et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhi-novirus bronchiolitis. Pediatr Infect Dis J 2012; 31:86-9.
23. Suárez-Arrabal MC, Mella C, Lopez SM, et al. Nasopharyngeal bacterial burden and antibiotics: Influence on infammatory markers and disease severity in infants with respiratory syncytial virus bronchiolitis. J Infect 2015; 71:458-69.
24. Nolte FS, Marshall DJ, Rasberry C, et al. MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol 2007; 45:2779-86.
25. Mejias A, Dimo B, Suarez NM, et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med 2013; 10:e1001549.
26. Heinonen S, Jartti T, Garcia C, et al. Rhinovirus detection in symptomatic and asymptomatic children: value of host transcriptome analysis. Am J Respir Crit Care Med 2016; 193:772-82.
27. Peret TC, Hall CB, Hammond G W, et al. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis 2000; 181:1891-6.
28. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) sofware version 4.0. Mol Biol Evol 2007; 24:1596-9.
29. Kumar S, Tamura K, Nei M. MEGA3: integrated sofware for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004; 5:150-63.
30. Tapia LI, Shaw CA, Aideyan LO, et al. Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in Texas. PLoS One 2014; 9:e90786.
31. Berry M P, Graham CM, McNab F W, et al. An interferon-in-ducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010; 466:973-7.
32. Banchereau R, Jordan-Villegas A, Ardura M, et al. Host immune transcriptional profiles refect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS One 2012; 7:e34390.
33. Chaussabel D, Quinn C, Shen J, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008; 29:150-64.
34. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncy-tial virus load predicts disease severity in previously healthy infants. J Infect Dis 2005; 191:1861-8.
35. Houben ML, Coenjaerts FE, Rossen JW, et al. Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol 2010; 82:1266-71.
36. Hall CB, Douglas RG Jr, Geiman JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 1975; 132:151-6.
37. Wright PF, Gruber WC, Peters M, et al. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002; 185:1011-8.
38. Hasegawa K, Jartti T, Mansbach JM, et al. Respiratory syncy-tial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis 2015; 211:1550-9.
39. Mazur NI, Bont L, Cohen AL, et al. Severity of respiratory syncytial virus lower respiratory tract infection with viral coinfection in HIV-uninfected children. Clin Infect Dis 2016; 64:443-50.
40. Scagnolari C, Midulla F, Selvaggi C, et al. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol 2012; 201:311-7.
41. Feikin DR, Fu W, Park DE, et al.; PERCH Study Group. Is higher viral load in the upper respiratory tract associated with severe pneumonia? Findings from the PERCH study. Clin Infect Dis 2017; 64:337-46.
42. Yoshihara K, Le MN, Okamoto M, et al. Association of RSV-A ON1 genotype with increased pediatric acute lower respiratory tract infection in Vietnam. Sci Rep 2016; 6:27856.
43. Luchsinger V, Ampuero S, Palomino MA, et al. Comparison of virological profiles of respiratory syncytial virus and rhi-novirus in acute lower tract respiratory infections in very young Chilean infants, according to their clinical outcome. J Clin Virol 2014; 61:138-44.
44. Panayiotou C, Richter J, Koliou M, Kalogirou N, Georgiou E, Christodoulou C. Epidemiology of respiratory syncytial virus in children in Cyprus during three consecutive winter seasons (2010-2013): age distribution, seasonality and association between prevalent genotypes and disease severity. Epidemiol Infect 2014; 142:2406-11.
45. Tran DN, Pham TM, Ha MT, et al. Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam. PLoS One 2013; 8:e45436.
46. Venter M, Collinson M, Schoub BD. Molecular epidemio-logical analysis of community circulating respiratory syncy-tial virus in rural South Africa: comparison of viruses and genotypes responsible for diferent disease manifestations. J Med Virol 2002; 68:452-61.
47. Otieno JR, Agoti CN, Gitahi CW, et al. Molecular evolutionary dynamics of respiratory syncytial virus group A in recurrent epidemics in Coastal Kenya. J Virol 2016; 90:4990-5002.
48. Hause AM, Henke DM, Avadhanula V, Shaw CA, Tapia LI, Piedra PA. Sequence variability of the respiratory syn-cytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B. PLoS One 2017; 12:e0175792.
49. Villenave R, Tavagnanam S, Sarlang S, et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci USA 2012; 109:5040-5.
50. Stokes KL, Chi MH, Sakamoto K, et al. Diferential patho-genesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol 2011; 85:5782-93.